Solventum Stock (NYSE:SOLV)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$72.46

52W Range

$47.16 - $76.05

50D Avg

$68.84

200D Avg

$62.05

Market Cap

$12.46B

Avg Vol (3M)

$1.13M

Beta

-0.25

Div Yield

-

SOLV Company Profile


Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.

Show More

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

22,000

IPO Date

Apr 01, 2024

Website

SOLV Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceJun 24
Product$1.60B

Fiscal year ends in Dec 23 | Currency in USD

SOLV Financial Summary


Dec 23Dec 22Dec 21
Revenue$8.24B$8.13B$8.17B
Operating Income$1.48B$1.69B$1.88B
Net Income$692.00M$1.34B$1.46B
EBITDA$2.04B$2.27B$2.48B
Basic EPS$4.01$7.79$8.47
Diluted EPS$4.01$7.79$8.47

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q2 24Aug 10, 24 | 2:39 PM